Autoantibodies Against Low-density Lipoprotein and Atherogenic Potential of Blood

References

• Chazov EI, Tertov VV, Orekhov AN, et al. Atherogenicity of blood serum from patients with coronary heart disease. Lancet 1986; 2: 595–8.
   PubMedGoogle Scholar
• Tertov VV, Orekhov AN, Martsenyuk ON, Perova NV, Smirnov VN. Low-density lipoproteins isolated from the blood of patients with coronary heart disease induce the accumulation of lipids in human aortic cells. Exp Mol Pathol 1989; 50: 337–47.
   PubMed Web of Science ®Google Scholar
• Orekhov AN, Tertov VV, Pokrovsky SN, et al. Blood serum atherogenicity associated with coronary atherosclerosis. Evidence for non-lipid factor providing atherogenicity of low-density lipoproteins and an approach to its elimination. Circ Res 1988; 62: 421–9.
   PubMed Web of Science ®Google Scholar
• Orekhov AN, Tertov VV, Mukhin DN, Mikhailenko IA. Modification of low density lipoprotein by desialylation causes lipid accumulation in cultured cells. Discovery of desialylated lipoprotein with altered cellular metabolism in the blood of atherosclerotic patients. Biochem Biophys Res Commun 1989; 162: 206–11.
   PubMed Web of Science ®Google Scholar
• Orekhov AN, Tertov VV, Kabakov AE, Adamova IYu, Pokrovsky SN, Smirnov VN. Autoantibodies against modified low density lipoprotein. Nonlipid factor of blood plasma that stimulates foam cell formation. Arterioscler Thromb 1991; 11: 316–26.
   PubMedGoogle Scholar
• Tertov VV, Orekhov AN, Kacharava AG, Sobenin IA, Perova NV, Smirnov VN. Low-density lipoprotein-containing circulating immune complexes and coronary atherosclerosis. Exp Mol Pathol 1990; 52: 300–8.
   PubMed Web of Science ®Google Scholar
• Tertov VV, Orekhov AN, Sayadyan KhS, et al. Correlation between cholesterol content and circulating immune complexes and atherogenic properties of CHD patients serum manifested in cell culture. Atherosclerosis 1990; 81: 183–9.
   PubMed Web of Science ®Google Scholar
• Campeau L. Grading of angina pectoris. Circulation 1976; 54: 522–3.
   PubMed Web of Science ®Google Scholar
• Judkins MP. Selective coronary radiography. A percutaneous transfemoral technique. Radiology 1967; 89: 980–90.
   Web of Science ®Google Scholar
• Creighton WD, Lambert PH, Misher PA. Detection of antibodies and soluble antigen-antibody complexes by precipitation with polyethylene glycol. J Immunol 1973; 111: 1219–23.
   PubMed Web of Science ®Google Scholar
• Beaumont JL, Doucet F, Vivier P, Antonucci M. Immunoglobulin-bound lipoproteins (Ig-Lp) as a marker of familial hypercholesterolaemia, xanthomatosis and atherosclerosis. Atherosclerosis 1988; 74: 191–201.
   PubMed Web of Science ®Google Scholar
• Orekhov AN, Khashimov KhA, Mukhin DN, et al. Low-density lipoprotein apheresis and regression of atherosclerotic plaque in vitro. Artif Organs 1986; 10: 466–9.
   PubMed Web of Science ®Google Scholar
• Phillips AP, Martin KL, Horton WH. The choice of methods of immunoglobulin IgG purification: yield and purity of antibody activity. J Immunol Meth 1984; 74: 385–93.
   PubMed Web of Science ®Google Scholar
• Tertov VV, Orekhov AN, Nikitina NA, et al. Peritoneal macrophages: a model for detecting atherogenic potential in patients' blood serum. Ann Med 1989; 21: 455–9.
   PubMed Web of Science ®Google Scholar
• Hara A, Radin NS. Lipid extraction of tissue with a low-toxicity solvent. Anal Biochem 1978; 90: 420–6.
   PubMed Web of Science ®Google Scholar
• Lindgren FT. Preparative ultracentrifugal laboratory procedures and suggestions for lipoprotein analysis. In: Perkins EG, ed. Analysis of Lipids and Lipoproteins. New York: American Oil Chemical Society, 1975; 205–24.
   Google Scholar
• DeLong DM, DeLong ER, Wood PD. A comparison of methods for the estimation of plasma low-and very low-density lipoprotein cholesterol. JAMA 1986; 256: 2372–7.
   PubMed Web of Science ®Google Scholar
• Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265–75.
   PubMed Web of Science ®Google Scholar
• Dixon WJ, Brown MB. Biomedical Computer Programs. P-Series. Berkeley: University of California Press, 1977: 185–98.
   Google Scholar
• Chazov EI, Orekhov AN, Tertov VV, et al. Atherogenicity of blood plasma from patients with coronary atherosclerosis and its correction. Atherosclerosis Rev 1988; 17: 9–20.
   Google Scholar
• Beaumont J-L, Beaumont V. Autoimmune hyperlipidemia. Atherosclerosis 1977; 26: 405–18.
   PubMed Web of Science ®Google Scholar
• Mitchinson MJ, Ball RY, Carpenter KLH, Parums DV. Macrophages and ceroid in atherosclerosis. In: Suckling KE, Groot PHE, eds. Hyperlipidaemia and atherosclerosis. London: Academic Press, 1988: 117–34.
   Google Scholar
• Noseda G, Riesen W, Schiumpf E, Morell A. Hypolipo-proteinemia associated with auto-antibodies against lipoproteins. Eur J Clin Invest 1972; 2: 342–9.
   PubMedGoogle Scholar
• Pallnski W, Rosenfeld ME, Yla-Herttuala S, et al. Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci USA 1989; 86: 1372–6.
   PubMed Web of Science ®Google Scholar
• Szondy E, Horvath M, Mezey Z, et al. Froe and complexed anti-lipoprotein antibodies in vascular diseases. Atherosclerosis 1983; 49: 69–77.
   PubMed Web of Science ®Google Scholar